Title: Brachytherapy
1Brachytherapy
2Definition
Brachytherapy comes from a Greek root meaning
from within or close by. It is the practice
of treating cancer by placing a radioactive
source(s) directly into the cancer tissue, thus
giving the radiation from the inside out, rather
than having to penetrate from the outside in
through normal tissues.
3Uses of Brachytherapy
- Form of nuclear medicine used only in early
detected carcinomas - Cancers
- Prostate
- Ultrasound
- Plan radiation
- Deliver to affected tissue
- Low or high dose
- Breast
- Ultrasound or X-ray
- Plan radiation
- Deliver
- Usually high dose
4Prostate Tumor
5Prostate
6Metastasizing Tumor
7Ultrasound Probe
8Prostate Ultrasound Image
9Build 3D Picture
10Radiation Planning
11Radiation Beads
125Iodine or 103Palladium
12Low Dose Radiation (Permanent)
X-ray of pelvis
13High Dose Radiation (Temporary)
14Clinical Procedure
15Perineal Template
16Inserting Needles
17Low Dose Brachytherapy
18High Dose Brachytherapy
19The Relaxed Patient
20Results
- A total of 551 consecutive patients were treated.
Of these, 320/551 (58) received implant alone
(Group I), and 231/551 (42)--considered higher
risk patients--were also treated with a modest
dose (45 Gy) of external beam irradiation (Group
II). The median follow-up for Group I was 55
months, and for Group II, 60 months. - At 7 years, the actuarial freedom from
biochemical failure (prostate-specific antigen
(PSA) lt or 1.0 ng/mL) was 80 in Group I
patients, and, at 8 years, 65 in Group II
patients. Morbidity was minimal if patients had
not undergone prior transurethral prostate
resections.
Brachytherapy for clinically localized prostate
cancer results at 7- and 8-year follow-up. Ragde
H, Blasko JC, Grimm PD, Kenny GM, Sylvester J,
Hoak DC, Cavanagh W, Landin K.
21Breast Cancer
Recurrence rates following lumpectomy and whole
breast external beam radiotherapy are
approximately 10. The majority of recurrences
are in the vicinity of the lumpectomy site. In
fact, only about 3.5 of recurrences are in
remote areas of the breast.
22Brachytherapy
23Brachytherapy
24Brachytherapy Treatments
25Current Standard Use
- Only selected breast cancer patients may be
candidates for this type of therapy. At the
minimum, early stage breast cancer patients must
meet all the following criteria 1.Tumor size
of 3 centimeters or less 2 No positive lymph
nodes - 3.Negative or clear margins around the tumor
4.Within 8 weeks of lumpectomy or within 3
weeks after finishing chemotherapy. - While studies using breast brachytherapy appear
to suggest that this treatment has promise, it is
important to point out that the data are still
preliminary and the technique should be
considered investigational.
26Results
The National Cancer Institute sponsored a trial
enrolling 196 patients. Results were reported in
Oct. 2002. Recurrence rates at 5 years were as
good as or superior to studies giving standard
external beam radiation therapy. No harmful side
effects were noted, and cosmetic results were
good to excellent in 92 of patients.